Today, PhRMA released a new resource on biopharmaceuticals in government programs. This new chart pack features key facts about prescription medicines in four major government programs – Medicare, Medicaid, Veterans Affairs and the 340B drug discount program.
Check out the chart pack here: http://www.phrma.org/gov-chartpack-2015
Below is a preview of the new resource.
Federal Spending on Health Care
Over the Next Decade:
Medicines in Medicare Part D
Beneficiaries Save Through Plan Competition and Manufacturer Negotiations
Medicines in Medicare Part B
Program Spending on Prescription Medicines Accounted for About 8% of Part B Spending in 2012
Medicines in Medicaid
On Average, About 60% of the Initial Cost of Brand Medicines is Returned to States Through Rebates
Medicines in Veterans Affairs
VA Formulary Covers Fewer Drugs Than Part D
Medicines in 340B
Without Significant Reforms 340B Will Continue to Grow as Uninsured Rate Declines
Allyson Funk Ally is a former senior director of public affairs at PhRMA focused on advocacy issues for the biopharmaceutical industry. Her expertise includes Medicare, Medicaid, 340B, health reform and more. Prior to PhRMA, her experience included leading health communications for a large membership organization, supporting public affairs clients and working for the governor of Louisiana.